Učitavanje...
Biomarkers of Drug-induced Liver Injury
Drug-induced liver injury (DILI) is a major clinical and regulatory challenge. As a result, interest in DILI biomarkers is growing. So far, considerable progress has been made in identification of biomarkers for diagnosis (acetaminophen-cysteine protein adducts), prediction (genetic biomarkers), and...
Spremljeno u:
| Izdano u: | Adv Pharmacol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7351790/ https://ncbi.nlm.nih.gov/pubmed/31307588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/bs.apha.2019.02.001 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|